FREE Account Opening + No Clearing Fees
Loading...

Glenmark Life Sciences IPO vs Zomato IPO

Comparision between Glenmark Life Sciences IPO and Zomato IPO.

IPO Details

Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Zomato IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Zomato IPO is up to ₹9,375.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Zomato IPO is ₹76.00 per share.

  Glenmark Life Sciences IPO Zomato IPO
Face Value ₹2 per share ₹1 per share
Issue Price (Lower) ₹695.00 per share ₹72.00 per share
Issue Price (Upper) ₹720.00 per share ₹76.00 per share
Issue Price (Final) ₹720.00 per share ₹76.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 20 shares 195 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹1,060.00 Cr up to ₹9,000.00 Cr
OFS Issue Size 63,00,000 shares
OFS Issue Size (Amount) up to ₹453.60 Cr up to ₹375.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,513.60 Cr up to ₹9,375.00 Cr

IPO Timetable

Glenmark Life Sciences IPO opens on Jul 27, 2021, while Zomato IPO opens on Jul 14, 2021. The closing date of Glenmark Life Sciences IPO and Zomato IPO is Jul 29, 2021, and Jul 16, 2021, respectively.

  Glenmark Life Sciences IPO Zomato IPO
Anchor Bid Date
Issue Open Jul 27, 2021 Jul 14, 2021
Issue Close Jul 29, 2021 Jul 16, 2021
Basis Of Allotment (Tentative) Aug 03, 2021 Jul 22, 2021
Initiation of Refunds (Tentative) Aug 04, 2021 Jul 23, 2021
Credit of Share (Tentative) Aug 05, 2021 Jul 23, 2021
Listing date (Tentative) Aug 06, 2021 Jul 23, 2021
Anchor Lockin End date 1 Sep 02, 2021 Aug 21, 2021
Anchor Lockin End date 2 Nov 01, 2021 Oct 20, 2021

Financials

Glenmark Life Sciences IPO P/E ratio is , as compared to Zomato IPO P/E ratio of .

  Glenmark Life Sciences IPO Zomato IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 19,970.75 17,256.04 14,753.95
Total Revenue 18,859.76 15,493.03 8,868.65
Profit After Tax 3,515.81 3,130.98 1,955.92
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 87,035.43 29,003.82 34,134.05
Total Revenue 21,184.24 27,427.39 13,977.17
Profit After Tax (8,164.28) (23,856.01) (10,105.14)
Promoter Shareholding (Pre-Issue) 100%
Promoter Shareholding (Post-Issue) 82.84%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Zomato IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 38,88,37,690 shares in Zomato IPO.

  Glenmark Life Sciences IPO Zomato IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 42,42,379 shares 38,88,37,690 shares
NII 32,32,770 shares 19,43,37,499 shares
RII 75,43,130 shares 12,95,58,333 shares
Employee 0 shares 65,00,000 shares
Others
Total 1,50,18,279 shares 71,92,33,522 shares

Bids Received (Subscription)

Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Zomato IPO subscribed 38.25x.

  Glenmark Life Sciences IPO Zomato IPO
QIB (times) 36.97x 51.79x
NII (times) 122.54x 32.96x
Big NII (times)
Small NII (times)
RII (times) 14.63x 7.45x
Employee (times) 0.62x
Other (times)
Total (times) 44.17x 38.25x

Comments

Add a public comment...